The who-when-why triangle of CAM use among Portuguese IBD patients.

[1]  V. Medici,et al.  Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission , 2016, Current Gastroenterology Reports.

[2]  B. Brzozowski,et al.  Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence , 2016, Pharmacological reports : PR.

[3]  M. Silverberg,et al.  Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study , 2016, Inflammatory bowel diseases.

[4]  A. Alarhayem,et al.  Psychosocial Support of the Inflammatory Bowel Disease Patient. , 2015, The Surgical clinics of North America.

[5]  Kívia Queiroz de Andrade,et al.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? , 2015, Redox biology.

[6]  J. Gálvez,et al.  Botanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A Review , 2015, Mediators of inflammation.

[7]  E. Szigethy.  Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan , 2015, The American journal of clinical hypnosis.

[8]  P. Gibson,et al.  Review article: gut‐directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease , 2015, Alimentary pharmacology & therapeutics.

[9]  J. Andrews,et al.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease. , 2015, World journal of gastroenterology.

[10]  J. Triantafillidis,et al.  Herbal and plant therapy in patients with inflammatory bowel disease , 2015, Annals of gastroenterology.

[11]  G. Nguyen,et al.  Practices and attitudes toward complementary and alternative medicine in inflammatory bowel disease: a survey of gastroenterologists , 2014, Journal of complementary & integrative medicine.

[12]  K. Labuzek,et al.  The emering role of helminths in treatment of the inflammatory bowel disorders. , 2014, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[13]  A. Lindberg,et al.  Experiences of complementary and alternative medicine in patients with inflammatory bowel disease – a qualitative study , 2014, BMC Complementary and Alternative Medicine.

[14]  M. Genua,et al.  Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine? , 2014, Expert review of gastroenterology & hepatology.

[15]  F. Sirois.  Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis. , 2014, Complementary therapies in medicine.

[16]  G. Moser.  The role of hypnotherapy for the treatment of inflammatory bowel diseases , 2014, Expert review of gastroenterology & hepatology.

[17]  J. Fichna,et al.  Chinese Herbal Medicines in the Treatment of IBD and Colorectal Cancer: A Review , 2014, Current Treatment Options in Oncology.

[18]  T. Kim,et al.  Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease , 2014, Intestinal research.

[19]  C. Poupardin,et al.  Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey , 2014, European journal of gastroenterology & hepatology.

[20]  J. Cha,et al.  Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea. , 2014, Complementary therapies in medicine.

[21]  A. Lindberg,et al.  Inflammatory bowel disease professionals’ attitudes to and experiences of complementary and alternative medicine , 2013, BMC Complementary and Alternative Medicine.

[22]  Luyi Wu,et al.  Acupuncture and Moxibustion for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2013, Evidence-based complementary and alternative medicine : eCAM.

[23]  R. Gearry,et al.  Use and Predictors of Oral Complementary and Alternative Medicine by Patients With Inflammatory Bowel Disease: A Population-Based, Case–Control Study , 2013, Inflammatory bowel diseases.

[24]  S. Vermeire,et al.  Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. , 2012, Journal of Crohn's & colitis.

[25]  M. S. Fagermoen,et al.  Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway , 2012, Scandinavian journal of gastroenterology.

[26]  J. E. Domínguez-Muñoz,et al.  Complementary and alternative medicine in inflammatory bowel disease patients: frequency and risk factors. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  M. Høivik,et al.  Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN). , 2012, Journal of Crohn's & colitis.

[28]  M. Silverberg,et al.  Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease , 2012, Alimentary Pharmacology and Therapeutics.

[29]  S. Joos.  Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease , 2011, Chinese journal of integrative medicine.

[30]  M. Verhoef,et al.  Use of complementary and alternative medicine by patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[31]  R. D'Incà,et al.  Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study. , 2010, Journal of Crohn's & colitis.

[32]  F. Nagy,et al.  Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. , 2010, Journal of Crohn's & colitis.

[33]  G. Lewith,et al.  Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). , 2009, Journal of alternative and complementary medicine.

[34]  G. Mullin,et al.  A review of complementary and alternative approaches to immunomodulation. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[35]  A. Buda,et al.  Use of alternative and complementary therapies by inflammatory bowel disease patients in an Italian tertiary referral centre. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[36]  S. Willich,et al.  Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease , 2006, BMC complementary and alternative medicine.

[37]  Laurent Beaugerie,et al.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. , 2006, Journal of Crohn's & colitis.

[38]  A. Michalsen,et al.  Amount of Systemic Steroid Medication Is a Strong Predictor for the Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.: Results From a German National Survey , 2005, Inflammatory bowel diseases.

[39]  D. Rampton,et al.  Use of Complementary Therapies by Patients with IBD May Indicate Psychosocial Distress , 2002, Inflammatory bowel diseases.